| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000009529 |
| Receipt No. | R000010880 |
| Scientific Title | Implication of clinical management in predialysis chronic renal failure and induction of hemodialysis, and incidents of cardiovascular events and vascular access failure in maintenance hemodialysis |
| Date of disclosure of the study information | 2013/01/01 |
| Last modified on | 2020/06/23 (Ver. 7) |
| Basic information | ||
| Public title | Implication of clinical management in predialysis chronic renal failure and induction of hemodialysis, and incidents of cardiovascular events and vascular access failure in maintenance hemodialysis | |
| Acronym | Implication of predialysis management and incidents of cardiovascular events and vascular access failure in maintenance hemodialysis | |
| Scientific Title | Implication of clinical management in predialysis chronic renal failure and induction of hemodialysis, and incidents of cardiovascular events and vascular access failure in maintenance hemodialysis | |
| Scientific Title:Acronym | Implication of predialysis management and incidents of cardiovascular events and vascular access failure in maintenance hemodialysis | |
| Region |
|
|
| Condition | |||
| Condition | Predialysis and hemodialysis chronic renal failure | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To investigate the effect of clinical management in predialysis renal failure and induction of hemodialysis on incidents of cardiovascular events and vascular access failure in early maintenance hemodialysis |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | 1) Cardiovascular events and death
Cardiovascular events: Myocardial infarction, stroke, revascularization of coronary artery (PCI/CABG), admission for heart failure and revascularization for arteriosclerotic obliterans 2) Vascular access failure Vascular access failure: occlusion of vascular access or intervention for the failure (Operation/PTA) |
| Key secondary outcomes | 1) All-caused death
2) All-caused admission |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Patients with chronic renal failure expected to initiate maintenance hemodialysis in clinical institutions which have accepted to participate in this study
2) Patients with the informed consent to this study by themselves or the relatives |
|||
| Key exclusion criteria | 1) Patients receiving dialysis for acute kidney injury
2) Patients with any events defined as the primary outcome in this study during the hospitalization for induction of maintenance hemodialysis 3) Patients with peritoneal dialysis 4) Patients with the past history of kidney transplantation 5) Patients receiving treatment for advanced cancer with unfavorable prognosis 6) Patients receiving treatment for severe infection with unfavorable prognosis 7) Patients with heart failure who feel the rest symptom (NYHA classification IV) 8) Patients who are unable to receive the outpatient hemodialysis by their walk after the induction 9) Patients judged as unsuitable for participating in this study by the attending physician |
|||
| Target sample size | 600 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Kawasaki Medical School | ||||||
| Division name | Department of Nephrology and Hypertension | ||||||
| Zip code | |||||||
| Address | 577 Matsushima, Kurashiki, Okayama 701-0192 | ||||||
| TEL | 086-462-1111 | ||||||
| tsasaki@med.kawasaki-m.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Kawasaki Medical School | ||||||
| Division name | Department of Nephrology and Hypertension | ||||||
| Zip code | |||||||
| Address | 577 Matsushima, Kurashiki, Okayama 701-0192 | ||||||
| TEL | 086-462-1111 | ||||||
| Homepage URL | |||||||
| hrn444k@med.kawasaki-m.ac.jp | |||||||
| Sponsor | |
| Institute | Department of Nephrology and Hypertension, Kawasaki Medical School |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Ministry of Health, Labour and Welfare |
| Organization | |
| Division | |
| Category of Funding Organization | |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | This research was canceled. |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | Investigate the effects of clinical factors in predialysis chronic renal failure and induction of hemodialysis on incidents of cardiovascular events and vascular access failure in maintenance hemodialysis. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000010880 |